MedPath
FDA Product

Ciprofloxacin

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Ciprofloxacin

70934-093

Regulatory Information

70934-093

ANDA077859

C73584

January 1, 2023

USA

These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987

HUMAN PRESCRIPTION DRUG LABEL

5

Company Information

Active Ingredients

CIPROFLOXACIN HYDROCHLORIDE

Quantity: 500 mg in 1 1

Code: 4BA73M5E37

Class Code: ACTIM

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

HYPROMELLOSE 2910 (5 MPA.S)

Code: R75537T0T4

Class Code: IACT

POVIDONE K30

Code: U725QWY32X

Class Code: IACT

POLYETHYLENE GLYCOL 400

Code: B697894SGQ

Class Code: IACT

SODIUM STARCH GLYCOLATE TYPE A POTATO

Code: 5856J3G2A2

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

Active Moieties

CIPROFLOXACIN

Code: 5E8K9I0O4U

© Copyright 2025. All Rights Reserved by MedPath